The effect of induction pegylated interferon alfa 2b and ribavirin on early virologic response in genotype 1 chronic hepatitis C

被引：0
|
作者：
Lawitz, EJ
Harrison, SA
Cantu, NS
Davis, M
Perkel, M
Vemuru, R
Nguyen, T
Kadakia, S
Ganeshappa, KP
Diamond, K
Matossian, H
Box, TD
Ghandour, E
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A723 / A723
页数：1
相关论文
共 50 条
  • [41] Sustained viral response to pegylated interferon α-2b and ribavirin in chronic hepatitis C refractory to prior treatment
    Mathew, A.
    Peiffer, L. P.
    Rhoades, K.
    McGarrity, T.
    DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (11) : 1956 - 1961
  • [42] Sustained Viral Response to Pegylated Interferon α-2b and Ribavirin in Chronic Hepatitis C Refractory to Prior Treatment
    A. Mathew
    L. P. Peiffer
    K. Rhoades
    T. McGarrity
    Digestive Diseases and Sciences, 2006, 51 : 1956 - 1961
  • [43] A randomized trial of pegylated interferon α-2b plus ribavirin in the retreatment of chronic hepatitis C
    Jacobson, IM
    Gonzalez, SA
    Ahmed, F
    Lebovics, E
    Min, AD
    Bodenheimer, HC
    Esposito, SP
    Brown, RS
    Bräu, N
    Klion, FM
    Tobias, H
    Bini, EJ
    Brodsky, N
    Cerulli, MA
    Aytaman, A
    Gardner, PW
    Geders, JM
    Spivack, JE
    Rahmin, MG
    Berman, DH
    Ehrlich, J
    Russo, MW
    Chait, M
    Rovner, D
    Edlin, BR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2453 - 2462
  • [44] Pegylated interferon alpha-2b (Peg-IFN α-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN α-2b plus ribavirin
    Oze, T.
    Hiramatsu, N.
    Yakushijin, T.
    Kurokawa, M.
    Igura, T.
    Mochizuki, K.
    Imanaka, K.
    Yamada, A.
    Oshita, M.
    Hagiwara, H.
    Mita, E.
    Ito, T.
    Inui, Y.
    Hijioka, T.
    Tamura, S.
    Yoshihara, H.
    Hayashi, E.
    Inoue, A.
    Imai, Y.
    Kato, M.
    Yoshida, Y.
    Tatsumi, T.
    Ohkawa, K.
    Kiso, S.
    Kanto, T.
    Kasahara, A.
    Takehara, T.
    Hayashi, N.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (08) : 578 - 585
  • [45] Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C
    Poynard, T
    GUT, 2003, 52 (10) : 1532 - 1532
  • [46] Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C
    Nomura, H.
    Miyagi, Y.
    Tanimoto, H.
    Ishibashi, H.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (05) : 346 - 351
  • [47] Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C
    Kim, WR
    Poterucha, JJ
    Gross, JB
    HEPATOLOGY, 2000, 31 (03) : 807 - 807
  • [48] Durability of Response in Children Treated With Pegylated Interferon alfa-2a ± Ribavirin for Chronic Hepatitis C
    Schwarz, Kathleen B.
    Molleston, Jean P.
    Jonas, Maureen M.
    Wen, Jessica
    Murray, Karen F.
    Rosenthal, Philip
    Gonzalez-Peralta, Regino P.
    Lobritto, Steven J.
    Mogul, Douglas
    Pavlovic, Vedran
    Warne, Charles
    Wat, Cynthia
    Thompson, Bruce
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 62 (01): : 93 - 96
  • [49] Virologic response in patients with chronic hepatitis C after treatment with interferon 2b alone or in combination with ribavirin.
    Futuh, ARA
    Solayman, AEM
    El Hendawy, SM
    El Hadad, SM
    Omar, MM
    Kamel, MM
    HEPATOLOGY, 2002, 36 (04) : 589A - 589A
  • [50] Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
    Davis, GL
    Wong, JB
    McHutchison, JG
    Manns, MP
    Harvey, J
    Albrecht, J
    HEPATOLOGY, 2003, 38 (03) : 645 - 652
12345